King International Investment (HKSE:00928) Change In Working Capital : HK$0.0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

What is King International Investment Change In Working Capital?

King International Investment's change in working capital for the quarter that ended in Sep. 2023 was HK$0.0 Mil.

King International Investment's change in working capital for the fiscal year that ended in Mar. 2023 was HK$-131.4 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

King International Investment Change In Working Capital Historical Data

The historical data trend for King International Investment's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

King International Investment Change In Working Capital Chart

King International Investment Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Working Capital

Get a 7-Day Free Trial

24.27

179.34

-193.55

102.96

-131.45

King International Investment Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Change In Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

King International Investment Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

King International Investment Change In Working Capital Related Terms

Thank you for viewing the detailed overview of King International Investment's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

King International Investment (HKSE:00928) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG

Website

https://www.lifehealthcare.com

King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

Executives

Wei Yan	2101 Beneficial owner
Wang Mengyao	2101 Beneficial owner
Wong Yat Fung	2101 Beneficial owner
Zhou Chun Yan	2101 Beneficial owner
Pioneer Environmental International Industries Company Limited	2101 Beneficial owner
Liu Na	2201 Interest of corporation controlled by you
Wang Wen	2101 Beneficial owner
Pang Zhen	2101 Beneficial owner

King International Investment (HKSE:00928) Headlines

No Headlines